Needham & Company LLC Trims Cara Therapeutics (NASDAQ:CARA) Target Price to $5.00
Cara Therapeutics (NASDAQ:CARA – Free Report) had its price target reduced by Needham & Company LLC from $6.00 to $5.00 in a report published on Monday morning, Benzinga reports. Needham & Company LLC currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also recently commented on the stock. […]
More Stories
ANyONe Protocol (ANYONE) Price Tops $0.83 on Major Exchanges
ANyONe Protocol (ANYONE) traded 5.4% lower against the dollar during the 24 hour period ending at 16:00 PM ET on...
Bitcoiva Reaches 24-Hour Volume of $271,003.18 (BCA)
Bitcoiva (BCA) traded 5% lower against the US dollar during the 1-day period ending at 16:00 PM Eastern on October...
ALL BEST ICO Price Up 96.9% Over Last Week (ALLBI)
ALL BEST ICO (ALLBI) traded down 95.5% against the US dollar during the 24 hour period ending at 16:00 PM...
Rep. Marjorie Taylor Greene Buys Caterpillar Inc. (NYSE:CAT) Stock
Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of Caterpillar Inc. (NYSE:CAT). In a filing disclosed on October 22nd, the...
Tango Therapeutics (NASDAQ:TNGX) Sets New 52-Week Low – Should You Sell?
Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report)’s share price hit a new 52-week low on Wednesday . The company...
Focusrite (LON:TUNE) Reaches New 52-Week Low – Here’s Why
Focusrite plc (LON:TUNE – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Wednesday ....